Guest Editor: G. Castaman GENE THERAPY FOR HEMOPHILIA: FACTS AND QUANDARIES IN THE 21ST CENTURY
Therapy for hemophilia has evolved in the last 40 years from plasma-based concentrates to recombinant proteins and, more recently, to non-factor therapeutics. Along this same timeline, research in adeno-associated virus (AAV) based gene therapy vectors has provided the framework for successful early...
Gardado en:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
PAGEPress Publications
2020-08-01
|
| Series: | Mediterranean Journal of Hematology and Infectious Diseases |
| Acceso en liña: | https://www.mjhid.org/index.php/mjhid/article/view/4255 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|